grey
space
About Us
      Technology      Investors      News / Events      Careers      Contact
Advanced Proteome Therapeutics - Enhancing Protein Therapeutics Through Selective Modification Advanced Proteome Therapeutics - Enhancing Protein Therapeutics Through Selective Modification
space
space
NEWS
 
space

April 29, 2013
Advanced Proteome Announces Agreement with the University of Iowa for Testing of Foundation Trinity™ Technology
more...
 

April 22, 2013
Advanced Proteome Receives Notice of Issuance for New US Patent
more...
 

March 14, 2013
Advanced Proteome Therapeutics Corporation Prepares Proprietary Protein Conjugates to be Tested for Anti-Cancer Activities
more...
 
space

TSX-V: APC

Advancing Targeted Therapies for
                                 the War Against Cancer


Advanced Proteome has developed a patent-pending technology that combines multiple anti-cancer therapies in a single agent to directly target cancer tumors. This type of agent, carrying multiple anti-cancer therapies, has exhibited greater potency, higher specificity, and less toxicity than individual therapies that can also attack healthy cells.

Our technology is based on a proprietary protein modification platform that can be used to attach entities to therapeutic proteins to enhance their properties and/or endow them with additional functions. Advanced, targeted therapies such as ours are intended to attack primarily cancer cells and are expected to dominate the anti-cancer therapeutics market in the near future.


CEO-CFO-logo

Advanced Proteome Therapeutics Corp is focused on developing a Protein Therapeutic that is Targeted and Combines Multiple Anti-Cancer Therapies for Greater Potency, Higher Specificity and Less Toxicity than Individual Therapies Read more..



Disclaimer






space
 
Website and branding by NextPhase Strategy